GENEDRIVE PLC — Remuneration Information 2023

May 31, 2023

National Storage Mechanism | Additional information

RNS Number : 0413B

Genedrive PLC

31 May 2023

genedrive plc

("genedrive" or the "Company")

Block Listing Returns

The Company confirms the block listing six monthly return for the period to 31 May 2023.

Name of applicant		genedrive plc
Name of scheme		2007 Share Option Scheme
Period of return:	From:	01 December 2022	To:	31 May 2023
Balance of unallocated securities under scheme(s) from previous return:		139,226 shares
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		7,500 shares
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		131,726 shares

In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.

Name of applicant		genedrive plc
Name of scheme		2017 Share Option Scheme
Period of return:	From:	19 May 2023	To:	31 May 2023
Balance of unallocated securities under scheme(s) from previous return:		1,150,588 shares
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		1,150,588 shares

Name of applicant		genedrive plc
Name of scheme		Unapproved Share Option Scheme
Period of return:	From:	19 May 2023	To:	31 May 2023
Balance of unallocated securities under scheme(s) from previous return:		2,668,144 shares
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		2,668,144  shares
Name of contact:		Russ Shaw CFO
Telephone number of contact:		+44 (0)161 989 0245

For enquires:

genedrive plc		+44 (0)161 989 0245
David Budd: CEO / Russ Shaw: CFO
Peel Hunt LLP (Nominated Adviser and Joint Broker)		+44 (0)20 7418 8900
James Steel / Oliver Duckworth
finnCap (Joint Broker)		+44 (0)20 7220 500
Geoff Nash / George Dollemore / Nigel Birks / Alice Lane
Walbrook PR Ltd (Media Relations & Investor Relations)	+44 (0)20 7933 8780 or genedrive@walbrookpr.com
Paul McManus / Anna Dunphy		+44 (0)7980 541 893 / +44 (0)7876 741 001

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRFLFILETIIVIV